Femoropopliteal and tibioperoneal artery reconstruction using human umbilical vein.
We used 99 human umbilical vein (HUV) grafts for femoropopliteal or tibioperoneal artery reconstruction in 94 patients. Results were calculated according to the life-table method for several categories possibly influencing graft patency. For above-knee v below-knee distal anastomosis, there was no difference in patency or limb-salvage rates at 30 months. Comparison of good and poor runoff situations disclosed similar 30-month graft patency rates, but significantly better limb-salvage rates among patients with good runoff. Primary revascularization fared significantly better than secondary procedures in terms of patency and limb salvage. We found no significant differences between HUV and polytef (polytetrafluoroethylene) for above-knee anastomoses or good runoff situations. However, patency and limb salvage were better for HUV use in below-knee anastomosis and poor runoff situations. The HUV may offer advantages in long-term patency and limb salvage in selected patients.
D000368:Aged; D001705:Bioprosthesis; D001807:Blood Vessel Prosthesis; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006085:Graft Survival; D006801:Humans; D007383:Intermittent Claudication / Q000601:surgery*; D007717:Knee; D007866:Leg / Q000098:blood supply; D008297:Male; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000601:surgery*; D012039:Regional Blood Flow; D013997:Time Factors; D014471:Umbilical Veins / Q000637:transplantation*
D011138:Polytetrafluoroethylene